13F Data
13F filer · CIK 1440771

Stonepine Capital Management, LLC

Bend, OR · filing since Q4 2015 · last filing Aug 17, 2026
Reported value
$177.3M
$-72.5M vs prior
Positions
87
New / sold out
25 / 21
Added / reduced
23 / 27
Turnover
28.5%
buys $60.8M · sells $148.1M
Top-10 weight
44.4%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewINSMED INCCALL+40,000–+$5.6M
NewELOXX PHARMACEUTICALS INC+397,160–+$5.5M
NewULTRAGENYX PHARMACEUTICAL INCALL+200,000–+$5.5M
NewMEDTRONIC PLCCALL+50,000–+$4.4M
NewINDIVIOR PHARMACEUTICALS INC+100,000–+$4.1M
NewABBOTT LABORATORIESCALL+40,000–+$3.8M
NewBOSTON SCIENTIFIC CORPCALL+50,000–+$3.3M
NewBIOMARIN PHARMACEUTICAL INCCALL+50,000–+$3.1M
AddedEDESA BIOTECH INC+426,439+1421.5%+$3.0M
AddedSATELLOS BIOSCIENCE INC+391,624+391.6%+$3.0M
38 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outSPDR SERIES TRUSTPUT-400,000-100.0%$-51.1M
Sold outSPDR SERIES TRUSTCALL-400,000-100.0%$-51.1M
ReducedADMA BIOLOGICS INCCALL-500,000-43.5%$-6.1M
Sold outTERNS PHARMACEUTICALS INCCALL-100,000-100.0%$-5.3M
ReducedTENAX THERAPEUTICS INC-315,200-32.3%$-4.6M
ReducedZEVRA THERAPEUTICS INC-221,299-46.1%$-3.2M
Sold outESTABLISHMENT LABS HLDGS INCCALL-50,000-100.0%$-2.8M
Sold outALEXANDRIA REAL ESTATE EQ INCALL-50,000-100.0%$-2.3M
Sold outACADIA PHARMACEUTICALS INCCALL-100,000-100.0%$-2.2M
Sold outXOMA ROYALTY CORPORATION-69,500-100.0%$-2.2M
38 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2015: $85.4MQ1 2016: $84.8MQ2 2016: $97.5MQ3 2016: $122.6MQ4 2016: $167.9MQ1 2017: $177.5MQ2 2017: $185.2MQ3 2017: $169.6MQ4 2017: $166.8MQ1 2018: $186.6MQ2 2018: $164.6MQ3 2018: $171.0MQ4 2018: $113.9MQ1 2019: $173.9MQ2 2019: $145.2MQ3 2019: $103.0MQ4 2019: $143.5MQ1 2020: $94.6MQ2 2020: $51.6MQ3 2020: $96.1MQ4 2020: $130.6MQ1 2021: $185.1MQ2 2021: $191.2MQ3 2021: $219.8MQ4 2021: $217.9MQ1 2022: $241.1MQ2 2022: $214.9MQ3 2022: $222.4MQ4 2022: $237.7MQ1 2023: $298.2MQ2 2023: $277.2MQ3 2023: $301.0MQ4 2023: $231.2MQ1 2024: $126.1MQ2 2024: $109.6MQ3 2024: $158.2MQ4 2024: $123.9MQ1 2025: $102.8MQ2 2025: $101.9MQ3 2025: $123.0MQ4 2025: $137.0MQ1 2026: $249.7MQ2 2026: $177.3M
Q4 2015Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1VERASTEM INCCOM NEW3,349,627$12.8M7.22%
2EVOLUS INCCOM1,590,162$11.0M6.23%
3TENAX THERAPEUTICS INCCOM NEW660,000$9.6M5.42%
4NEKTAR THERAPEUTICSCOM NEW120,654$8.4M4.75%
5ADMA BIOLOGICS INCCALLCOM650,000$8.0M4.48%
6ADMA BIOLOGICS INCCOM740,000$6.2M3.49%
7CAMP4 THERAPEUTICS CORPCOM 13469V AB 4 CAMTEK LTD NOTE 12/01,389,622$6.1M3.43%
8INSMED INCCALLCOM PAR $.0140,000$5.6M3.16%
9ELOXX PHARMACEUTICALS INCCOM NEW397,160$5.5M3.11%
10ULTRAGENYX PHARMACEUTICAL INCALLCOM200,000$5.5M3.10%
77 more rows. Subscribe for $29/month to see every row, download the data and use the API.